European Journal of Anaesthesiology· 2015Q1
Avrupa'da Kronik Ameliyat Sonrası Ağrı
Chronic postsurgical pain in Europe
- 597atıf
- Q1SCImago
- 2015yıl
Kısa özet
Avrupa'daki bir kayıt sistemi, hastaların %11,8'inin ameliyattan bir yıl sonra orta ila şiddetli kronik ameliyat sonrası ağrı (KASA) geliştirdiğini ve bu vakaların üçte birinden fazlasında nöropatik ağrı belirtileri bulunduğunu ortaya koydu.
Yapay zekâ ile başlık ve abstract'tan üretildi; tam metin okunmaz.
Ana noktalar
- Hastaların %11,8'inde 12 ayda orta ila şiddetli kronik ameliyat sonrası ağrı (KASA) gelişti.
- Orta dereceli KASA vakalarının %35,4'ünde ve şiddetli KASA vakalarının %57,1'inde nöropatik ağrı belirtileri görüldü.
- Fonksiyonel bozulma, KASA şiddeti ve nöropatik özelliklerle birlikte arttı.
- Risk faktörleri arasında ortopedik cerrahi, ameliyat öncesi kronik ağrı ve ameliyat sonrası 1. günde şiddetli ağrı süresi yer aldı.
Yapay zekâ ile başlık ve abstract'tan üretildi; tam metin okunmaz.
Özet (abstract)
BACKGROUND: Chronic postsurgical pain (CPSP) is an important clinical problem. Prospective studies of the incidence, characteristics and risk factors of CPSP are needed. OBJECTIVES: The objective of this study is to evaluate the incidence and risk factors of CPSP. DESIGN: A multicentre, prospective, observational trial. SETTING: Twenty-one hospitals in 11 European countries. PATIENTS: Three thousand one hundred and twenty patients undergoing surgery and enrolled in the European registry PAIN OUT. MAIN OUTCOME MEASURES: Pain-related outcome was evaluated on the first postoperative day (D1) using a standardised pain outcome questionnaire. Review at 6 and 12 months via e-mail or telephonic interview used the Brief Pain Inventory (BPI) and the DN4 (Douleur Neuropathique four questions). Primary endpoint was the incidence of moderate to severe CPSP (numeric rating scale, NRS ≥3/10) at 12 months. RESULTS: For 1044 and 889 patients, complete data were available at 6 and 12 months. At 12 months, the incidence of moderate to severe CPSP was 11.8% (95% CI 9.7 to 13.9) and of severe pain (NRS ≥6) 2.2% (95% CI 1.2 to 3.3). Signs of neuropathic pain were recorded in 35.4% (95% CI 23.9 to 48.3) and 57.1% (95% CI 30.7 to 83.4) of patients with moderate and severe CPSP, respectively. Functional impairment (BPI) at 6 and 12 months increased with the severity of CPSP (P < 0.01) and presence of neuropathic characteristics (P < 0.001). Multivariate analysis identified orthopaedic surgery, preoperative chronic pain and percentage of time in severe pain on D1 as risk factors. A 10% increase in percentage of time in severe pain was associated with a 30% increase of CPSP incidence at 12 months. CONCLUSION: The collection of data on CPSP was feasible within the European registry PAIN OUT. The incidence of moderate to severe CPSP at 12 months was 11.8%. Functional impairment was associated with CPSP severity and neuropathic characteristics. Risk factors for CPSP in the present study were chronic preoperative pain, orthopaedic surgery and percentage of time in severe pain on D1. TRIAL REGISTRATION: Clinicaltrials.gov identifier: NCT01467102.
Yazarların özeti; kaynağından alınmıştır. European Journal of Anaesthesiology, 2015 · DOI ↗
Ücretsiz hesapla devam et
Makaleye Sor ile bu makaleye günde 3 soru ücretsiz; makaleyi kaydet, kaynakçasını al, ilgi alanına göre her gün yeni özetler. Çıkarımlar Premium.
Web'de ücretsiz devam etGoogle ya da Apple hesabınla giriş; kart istemez. Bu makaleye geri dönersin.
Telefonda:
Alan: Anesteziyoloji ve Ağrı Tıbbı
Anesthesiology and Pain MedicineMedicine